HEM Pharma Inc. (KOSDAQ:376270)
South Korea · Delayed Price · Currency is KRW 70,000
-2,200 (-3.05%)
At close: Mar 19, 2026
HEM Pharma Market Cap
HEM Pharma has a market cap or net worth of 502.02 billion as of March 20, 2026. Its market cap has increased by 310.17% in one year.
Market Cap
502.02B
Enterprise Value
509.51B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
70,000.00
Market Cap Chart
Since November 5, 2024, HEM Pharma's market cap has increased from 114.18B to 502.02B, an increase of 339.68%. That is a compound annual growth rate of 194.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 502.02B | 53.29% |
| Dec 30, 2025 | 327.49B | 185.09% |
| Dec 30, 2024 | 114.87B | 0.61% |
| Nov 5, 2024 | 114.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 1.43T |
| Myung In Pharmaceutical LTD. | 852.64B |
| Samyang Biopharm | 653.61B |
| ImmuneOncia Therapeutics | 630.40B |
| CellBion | 344.53B |
| DAE HWA Pharmaceutical | 257.32B |
| NOVAREX | 237.74B |
| GREEN CROSS WellBeing | 182.42B |